PlainRecalls
FDA Drug Moderate Class II Terminated

Rasagiline Mesylate Tablets 1 mg; 30 tablets in HDPE bottle; Rx only; NDC 67877-260-30; Manufactured by Alkem Laboratories Ltd., India; Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054

Reported: January 25, 2023 Initiated: December 28, 2022 #D-0159-2023

Product Description

Rasagiline Mesylate Tablets 1 mg; 30 tablets in HDPE bottle; Rx only; NDC 67877-260-30; Manufactured by Alkem Laboratories Ltd., India; Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054

Reason for Recall

Presence of Foreign Substance- A complaint was received of black spots/shiny metallic speck on the tablets.

Details

Recalling Firm
Ascend Laboratories, LLC
Units Affected
12192 bottles
Distribution
Customers in 19 states: CA, FL, GA, IL, KY, LA, MI, MN, MS, NC, NJ, NY, OH, PA, RI, TN, TX, WA, WI; Puerto Rico
Location
Parsippany, NJ

Frequently Asked Questions

What product was recalled?
Rasagiline Mesylate Tablets 1 mg; 30 tablets in HDPE bottle; Rx only; NDC 67877-260-30; Manufactured by Alkem Laboratories Ltd., India; Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054. Recalled by Ascend Laboratories, LLC. Units affected: 12192 bottles.
Why was this product recalled?
Presence of Foreign Substance- A complaint was received of black spots/shiny metallic speck on the tablets.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 25, 2023. Severity: Moderate. Recall number: D-0159-2023.